Altre lingue Solara Active Pharma Sciences Limited

Azioni

SOLARA

INE624Z01016

Tempo differito NSE India S.E. Altri mercati azionari 06:39:49 25/04/2024			Variaz. 5gg	Var. 1 gen.
554,2 ^INR	+0,46%		+16,93%	+53,40%

08/04	Solara Active Pharma Sciences Limited approva la nomina di Mohan Muthunarayanan come direttore esecutivo	CI
26/03	Solara Active Pharma ottiene l'approvazione del Consiglio di Amministrazione per vendere il 100% della partecipazione in SeQuent Penems	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Solara Active Pharma Sciences Limited Approves Appointment of Mohan Muthunarayanan as an Executive Director	08/04
Solara Active Pharma Gets Board Nod to Sell 100% Stake in SeQuent Penems	26/03
An undisclosed buyer agreed to acquire SeQuent Penems Private Limited from Solara Active Pharma Sciences Limited.	25/03
Solara Active Pharma Sciences Appoints CFO	08/03
Solara Active Pharma Sciences Limited Approves Appointment of Arun Kumar Baskaran as Chief Financial Officer	08/03
Solara Active Pharma Sciences' Human Resource Chief Resigns	27/02
Solara Active Pharma HR Chief Steps Down	26/02
Solara Active Pharma Sciences Limited Announces Resignation of Pagadala Srinivasan as Chief Human Resource Officer	26/02
Solara Active Pharma Sciences' CFO Resigns	15/02
Solara Active Pharma Sciences Limited Announces the Resignation of P.V. Raghavendra Rao as Chief Financial Officer	14/02
Solara Active Pharma Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Solara Active to Sell Subsidiary's Land	15/11
Solara Active Pharma Sciences Widens Consolidated Loss in Fiscal Q2	14/11
Solara Active Pharma Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11
Fire Breaks Out at Solara Active Pharma's Puducherry, India Unit	06/11
Solara Active Pharma Names CFO	20/10/23
Solara Active Pharma Sciences Limited Appoints P V Raghavendra Rao as Chief Financial Officer	19/10/23
Solara Active Pharma Sciences Limited Announces Reconstitution of the Committees	14/08/23
Solara Active Pharma Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23
Solara Active Pharma's Tamil Nadu Plant in India Clears US FDA Inspection	07/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Solara Active Pharma Sciences Limited

Azioni

SOLARA

INE624Z01016

Altre lingue

Filtri